A Double-Blind, Placebo-Controlled Trial of Zonisamide (Zonegran) in the Treatment of Essential Tremor

Theresa A. Zesiewicz; C. L. Ward; J. F. Staffetti; P. B. Dunne; Kelly L. Sullivan

A Double-Blind, Placebo-Controlled Trial of Zonisamide (Zonegran) in the Treatment of Essential Tremor

Theresa A. Zesiewicz, C. L. Ward, J. F. Staffetti, P. B. Dunne, Kelly L. Sullivan

Biostatistics, Epidemiology & Environmental Health Sciences

University of South Florida

Research output: Contribution to conference › Presentation

Abstract

This presentation was given at the American Academy of Neurology Annual Meeting.

Original language	American English
State	Published - Apr 5 2006
Event	American Academy of Neurology Annual Meeting (AAN) - Duration: Apr 23 2018 → …

Conference

Conference	American Academy of Neurology Annual Meeting (AAN)
Period	04/23/18 → …

Disciplines

Public Health
Epidemiology

Keywords

Double-blind
Essential tremor
Placebo-controlled trial
Treatment
Zonegran
Zonisamide

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@conference{a51985832e27428c98ede153e2cebba6,

title = "A Double-Blind, Placebo-Controlled Trial of Zonisamide (Zonegran) in the Treatment of Essential Tremor",

abstract = " This presentation was given at the American Academy of Neurology Annual Meeting.",

keywords = "Double-blind, Essential tremor, Placebo-controlled trial, Treatment, Zonegran, Zonisamide",

author = "Zesiewicz, {Theresa A.} and Ward, {C. L.} and Staffetti, {J. F.} and Dunne, {P. B.} and Sullivan, {Kelly L.}",

year = "2006",

month = apr,

day = "5",

language = "American English",

note = "American Academy of Neurology Annual Meeting (AAN) ; Conference date: 23-04-2018",

}

TY - CONF

T1 - A Double-Blind, Placebo-Controlled Trial of Zonisamide (Zonegran) in the Treatment of Essential Tremor

AU - Zesiewicz, Theresa A.

AU - Ward, C. L.

AU - Staffetti, J. F.

AU - Dunne, P. B.

AU - Sullivan, Kelly L.

PY - 2006/4/5

Y1 - 2006/4/5

N2 - This presentation was given at the American Academy of Neurology Annual Meeting.

AB - This presentation was given at the American Academy of Neurology Annual Meeting.

KW - Double-blind

KW - Essential tremor

KW - Placebo-controlled trial

KW - Treatment

KW - Zonegran

KW - Zonisamide

M3 - Presentation

T2 - American Academy of Neurology Annual Meeting (AAN)

Y2 - 23 April 2018

ER -

A Double-Blind, Placebo-Controlled Trial of Zonisamide (Zonegran) in the Treatment of Essential Tremor

Abstract

Conference

Disciplines

Keywords

UN SDGs

Fingerprint

Cite this